Wang et al., demonstrated that CDK6 can phosphorylate and inhibit two rate-limiting enzymes in the glucose metabolism pathway, PFKP and PKM2, in T-cell acute lymphoblastic leukemia (T-ALL). The gene discussed is CDK6; the disease is acute lymphoblastic leukemia.